Needham Maintains Buy on Veracyte, Raises Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on Veracyte (NASDAQ:VCYT) and raises the price target from $30 to $33, indicating a positive outlook on the company's stock.
February 23, 2024 | 10:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a Buy rating on Veracyte and raises the price target from $30 to $33, showing confidence in the company's future performance.
The increase in price target by a reputable analyst suggests a strong belief in the company's potential for growth and profitability, which is likely to positively influence investor sentiment and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100